Presenting company: Enzychem Lifesciences

Enzychem Lifesciences,  Corp. (KOSDAQ:183490) is a global biopharmaceutical company based in Seoul, Korea, that is is developing EC-18, an immune modulator that is in development in oncology, anti-inflammatory diseases and NASH. The compound is currently in three clinical trials: Phase 2 studies in Chemotherapy Induced Neutropenia (CIN), Chemoradiation Induced Oral Mucositis (CRIOM), and Acute Radiation Syndrome (ARS). For more information on Enzychem Lifesciences, visit  http://www.enzychem.com/

Click hereto RSVP

Everyone have a great safe and successful summer- see you in September. If you have any companies that have that special something, we are starting to put the fall/winter schedule and always interested in seeing what is new and exciting.

We look forward to seeing you on the evening of September 12th!

John Lieberman

Please be aware that security is at a high level, and you will not be able to enter the building without being on the NYC MedTech security list. No admittance will be allowed without confirmation and will be at the offices of SUNY Global Center 116 East 55th Street, New York, NY 10022.